Bio Green Med Solution, Inc. (BGMS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 300K 600K 900K Q2 '10: 119K Q3 '10: 159K Q1 '11: 192K Q2 '11: 168K Q3 '11: 164K Q4 '11: 175K Q1 '12: 161K Q2 '12: 26K Q3 '12: 38K Q1 '13: 212K Q2 '13: 264K Q3 '13: 309K Q4 '13: 299K Q1 '14: 396K Q2 '14: 356K Q3 '14: 735K Q4 '14: 247K Q1 '15: 512K Q2 '15: 296K Q3 '15: 715K Q4 '15: 421K Q1 '16: 139K Q2 '16: 222K Q3 '16: 205K Q4 '16: 277K Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 150K Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q1 '20: 0 Q2 '20: 0 Q3 '20: 0 Q4 '20: 0 Q1 '21: 0 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '22: 0 Q2 '22: 0 Q3 '22: 0 Q4 '22: 0 Q1 '23: 0 Q2 '23: 373K Q3 '23: 16K Q4 '23: 31K Q1 '24: 29K Q2 '24: 4K Q3 '24: 10K Q4 '24: 0 Q3 '25: 81K Q4 '25: 666K Q1 '26: 778K Q2 '26: 336K Q2 '11 Q3 '13 Q3 '15 Q3 '17 Q3 '19 Q4 '21 Q4 '23 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q1 '10: -4.4M Q2 '10: -4.4M Q3 '10: -4M Q4 '10: -2.3M Q1 '11: -4.8M Q2 '11: -3.8M Q3 '11: -3.9M Q4 '11: -3.7M Q1 '12: -3.1M Q2 '12: -3.8M Q3 '12: -3.5M Q4 '12: -4.7M Q1 '13: -4.1M Q2 '13: -4.2M Q3 '13: -5.8M Q4 '13: -4M Q1 '14: -5.4M Q2 '14: -5.6M Q3 '14: -5.7M Q4 '14: -5.8M Q1 '15: -5.3M Q2 '15: -3.6M Q3 '15: -3.4M Q4 '15: -3.9M Q1 '16: -3.7M Q2 '16: -3.8M Q3 '16: -3.5M Q4 '16: -3.2M Q1 '17: -2.7M Q2 '17: -2.5M Q3 '17: -2.1M Q4 '17: -2.2M Q1 '18: -2.2M Q2 '18: -2.5M Q3 '18: -2.5M Q4 '18: -2.5M Q1 '19: -2.2M Q2 '19: -2.3M Q3 '19: -2.3M Q4 '19: -2.8M Q1 '20: -2.4M Q2 '20: -2.5M Q3 '20: -2.6M Q4 '20: -3.2M Q1 '21: -4.3M Q2 '21: -6.1M Q3 '21: -6M Q4 '21: -6.3M Q1 '22: -6.6M Q2 '22: -5.8M Q3 '22: -6.5M Q4 '22: -8.8M Q1 '23: -7.3M Q2 '23: -5.9M Q3 '23: -6.8M Q4 '23: -5.4M Q1 '24: -4.4M Q2 '24: -3.6M Q3 '24: -2.2M Q4 '24: -1.8M Q1 '25: -822K Q2 '25: -68K Q3 '25: -992K Q4 '25: -1.1M Q1 '26: -246K Q2 '26: -418K Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income Quarterly

-9M -6M -3M 0 3M 6M 9M Q1 '10: -5.1M Q2 '10: -3.9M Q3 '10: -3.8M Q4 '10: -3.2M Q1 '11: -4.6M Q2 '11: -3.6M Q3 '11: -3.4M Q4 '11: -3.7M Q1 '12: -3M Q2 '12: -3.6M Q3 '12: -1.9M Q4 '12: -4.8M Q1 '13: -3.1M Q2 '13: 1.5M Q3 '13: -5M Q4 '13: -3.6M Q1 '14: -4.9M Q2 '14: -4.8M Q3 '14: -4.9M Q4 '14: -4.8M Q1 '15: -4.9M Q2 '15: -3.3M Q3 '15: -2.7M Q4 '15: -3.4M Q1 '16: -3M Q2 '16: -3M Q3 '16: -2.9M Q4 '16: -2.8M Q1 '17: -1.6M Q2 '17: -2.2M Q3 '17: -1.9M Q4 '17: -1.9M Q1 '18: -1.3M Q2 '18: -1.9M Q3 '18: -2.1M Q4 '18: -2M Q1 '19: -1.8M Q2 '19: -1.8M Q3 '19: -1.9M Q4 '19: -2.3M Q1 '20: -1.2M Q2 '20: -2.2M Q3 '20: -2.3M Q4 '20: -2.8M Q1 '21: -3.5M Q2 '21: -5.1M Q3 '21: -5M Q4 '21: -5.1M Q1 '22: -4.1M Q2 '22: -4.6M Q3 '22: -5.1M Q4 '22: -7.4M Q1 '23: -5.8M Q2 '23: -5.4M Q3 '23: -6M Q4 '23: -5.3M Q1 '24: -2.9M Q2 '24: -3.3M Q3 '24: -2M Q4 '24: -3.1M Q1 '25: -81K Q2 '25: -1.3M Q3 '25: -988K Q4 '25: -611K Q1 '26: -197K Q2 '26: -405K Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '10: -2.5M Q1 '11: -3.9M Q2 '11: -4.6M Q3 '11: -2.3M Q4 '11: -3.3M Q1 '12: -3.8M Q2 '12: -3.7M Q3 '12: -2.1M Q4 '12: -2.5M Q1 '13: -5.4M Q2 '13: -5.3M Q3 '13: -2.1M Q4 '13: -5.4M Q1 '14: -4.7M Q2 '14: -4.1M Q3 '14: -6.2M Q4 '14: -3.7M Q1 '15: -4.9M Q2 '15: -2.8M Q3 '15: -4.1M Q4 '15: -2.7M Q1 '16: -3.1M Q2 '16: -1M Q3 '16: -3M Q4 '16: -2.9M Q1 '17: -3.8M Q2 '17: -201K Q3 '17: -1.2M Q4 '17: -2.2M Q1 '18: -2.1M Q2 '18: -1.8M Q3 '18: -723K Q4 '18: -2M Q1 '19: -3.7M Q2 '19: -2.6M Q3 '19: -2M Q4 '19: -1.1M Q1 '20: -2.8M Q2 '20: -1.8M Q3 '20: -2.1M Q4 '20: -1.2M Q1 '21: -3.6M Q2 '21: -4.2M Q3 '21: -6.2M Q4 '21: -4.5M Q1 '22: -6.8M Q2 '22: -1.9M Q3 '22: -7M Q4 '22: -5.2M Q1 '23: -6.9M Q2 '23: -1.3M Q3 '23: -4M Q4 '23: -3.9M Q1 '24: -483K Q2 '24: -3.1M Q3 '24: -3.1M Q4 '24: -1.4M Q1 '25: -3.2M Q2 '25: -1.1M Q3 '25: -434K Q4 '25: -33K Q1 '26: -278K Q2 '26: -352K Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '10: -2.5M Q3 '11: -2.3M Q4 '11: -3.3M Q1 '12: -3.8M Q2 '12: -3.7M Q3 '12: -2.1M Q4 '12: -2.5M Q1 '13: -5.5M Q2 '13: -5.3M Q3 '13: -2.1M Q4 '13: -5.5M Q1 '14: -4.8M Q2 '14: -4.1M Q3 '14: -6.4M Q4 '14: -3.7M Q1 '15: -4.9M Q2 '15: -2.8M Q3 '15: -4.1M Q4 '15: -2.7M Q1 '17: -3.8M Q2 '17: -201K Q3 '17: -1.3M Q4 '17: -2.2M Q1 '18: -2.2M Q2 '18: -1.8M Q3 '18: -725K Q4 '18: -2M Q1 '19: -3.7M Q2 '19: -2.6M Q3 '19: -2M Q4 '19: -1.1M Q1 '20: -2.8M Q2 '20: -1.8M Q3 '20: -2.2M Q4 '20: -1.2M Q1 '21: -3.6M Q2 '21: -4.3M Q3 '21: -6.2M Q4 '21: -4.6M Q1 '22: -6.8M Q2 '22: -1.9M Q3 '22: -7M Q4 '22: -5.2M Q1 '23: -6.9M Q2 '23: -1.3M Q3 '23: -4M Q4 '23: -3.9M Q3 '24: -3.1M Q1 '26: -279K Q2 '26: -352K Q3 '10 Q1 '13 Q4 '14 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q2 '10: 36.6M Q3 '10: 37M Q1 '11: 46.6M Q2 '11: 46.6M Q3 '11: 7.7M Q1 '12: 7.8M Q2 '12: 8.4M Q3 '12: 8.4M Q1 '13: 9.8M Q2 '13: 13.9M Q3 '13: 17.8M Q1 '14: 19.5M Q2 '14: 22.6M Q1 '21: 7M Q2 '21: 9.2M Q3 '21: 9.4M Q1 '22: 10M Q2 '22: 10.1M Q3 '22: 12.3M Q1 '23: 12.5M Q2 '23: 12.6M Q3 '24: 44.7K Q1 '25: 365.2K Q2 '25: 1.4M Q3 '25: 1.9M Q1 '26: 5.5M Q2 '26: 5.6M Q1 '11 Q2 '12 Q3 '13 Q2 '21 Q3 '22 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-240.00 -160.00 -80.00 0.00 80.00 160.00 240.00 Q4 '11: -1.14 Q1 '12: -1.44 Q2 '12: -1.81 Q3 '12: -1.59 Q4 '12: -1.69 Q1 '14: -0.60 Q2 '14: -0.92 Q3 '14: -0.82 Q4 '14: -0.90 Q1 '15: -0.84 Q2 '15: -1.81 Q3 '15: -2.54 Q4 '15: -3.49 Q1 '16: -4.34 Q2 '16: -4.16 Q3 '16: -4.07 Q4 '16: -3.52 Q1 '17: -2.86 Q2 '17: -2.35 Q3 '17: -2.40 Q4 '17: -1.95 Q1 '18: -1.69 Q2 '18: -1.35 Q3 '18: -0.62 Q4 '18: -0.63 Q1 '19: -3.28 Q2 '19: -5.25 Q3 '19: -7.34 Q4 '19: -9.93 Q1 '20: -8.64 Q2 '20: -7.09 Q3 '20: -5.29 Q4 '20: -4.14 Q1 '21: -3.16 Q2 '21: -3.14 Q3 '21: -3.21 Q4 '21: -2.11 Q1 '22: -2.03 Q2 '22: -1.93 Q3 '22: -1.81 Q4 '22: -27.25 Q4 '24: -230.70 Q1 '25: -228.43 Q2 '25: -57.23 Q3 '25: -14.74 Q4 '25: -5.88 Q3 '12 Q1 '15 Q3 '16 Q1 '18 Q3 '19 Q1 '21 Q3 '22 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.